000 | 01161 a2200277 4500 | ||
---|---|---|---|
005 | 20250513214640.0 | ||
264 | 0 | _c20001103 | |
008 | 200011s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1086/313891 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCohn, D L | |
245 | 0 | 0 |
_aTreatment of latent tuberculosis infection: renewed opportunity for tuberculosis control. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJul 2000 |
||
300 |
_a120-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibiotics, Antitubercular _xtherapeutic use |
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
650 | 0 | 4 | _aTuberculin Test |
650 | 0 | 4 |
_aTuberculosis _xclassification |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 31 _gno. 1 _gp. 120-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/313891 _zAvailable from publisher's website |
999 |
_c10863181 _d10863181 |